Aug 2026· International Journal of Molecular Sciences· Vol 27, pp. 7395· 2 citations· 318 references
Medicine
TL;DR
Understanding these phenotypes can guide the identification of biomarkers and the development of personalized therapeutic strategies, thereby moving beyond one-size-fits-all approaches to the management of sepsis and septic shock.
Abstract
Considered a global public health priority, sepsis is characterized by life-threatening organ dysfunction caused by a dysregulated host response to infection. Its heterogeneous clinical presentation arises, in part, from pre-existing chronic conditions such as hypertension, metabolic syndrome, diabetes, alcohol exposure, psychosocial stress, and periodontitis, which induce persistent systemic changes even before the infectious event. This narrative review synthesizes evidence from experimental models and clinical studies to clarify the molecular and immunological mechanisms by which chronic conditions influence the septic state. We discuss how these conditions converge on common pathophysiological mechanisms, including low-grade chronic inflammation, oxidative stress, endothelial and mitochondrial dysfunction, and changes in the microbiota and neuroimmune regulation. Pathways such as TLR-NF-κB signaling and the NLRP3 inflammasome are maintained in a basal state of activation, lowering the threshold for hyperinflammatory responses and increasing the risk of multiple organ dysfunction syndrome. In conclusion, understanding these phenotypes can guide the identification of biomarkers and the development of personalized therapeutic strategies, thereby moving beyond one-size-fits-all approaches to the management of sepsis and septic shock.
Obesity has emerged as a major global public health concern. It is a
multifactorial condition encompassing genetic, environmental, socioeconomic, and psychosocial
factors. This narrative review aims to highlight the key pathophysiological processes associated
with chronic low-grade inflammation (CLGI) in obesity....
Nidhi Singh, Avijit Mazumder, Priyanka Bansal· Current Signal Transduction...· 0 citations
INTRODUCTION
Inflammatory bowel disease (IBD) is a chronic and relapsing disorder of the gastrointestinal tract. Its prevalence has risen rapidly, and nowadays it is a global health concern. Currently available medications reduce inflammation and alleviate the symptoms, but do not cure the disease. Recent findings sugg...
Karolina Merecz, J. Jarząbek, Jakub Fichna· Expert Review of Gastroenter...· 0 citations
This review synthesizes current knowledge on the molecular drivers linking redox imbalance, inflammatory signaling, adipokine dysregulation, mitochondrial dysfunction, AGE–RAGE activation, and gut microbiota alterations to metabolic dysfunction to provide an updated mechanistic framework for precision interventions aim...
P. Ojo, D. Rotimi, Emmanuel Henry Ezenabor et al.· Discover medicine· 0 citations
Although targeted modulation of inflammasome pathways represents a promising therapeutic strategy, further research is needed to refine patient selection, identify reliable biomarkers, and better characterise disease heterogeneity to enable successful clinical translation.
Caroline Neumann, Florian Hickl, Julia Kemnitzer et al.· Critical Care· 0 citations
BACKGROUND
Sepsis remains one of the leading causes of death around the world. For many years, sepsis was thought to activate the systemic inflammatory response syndrome in the presence of infection. We now know that this is not true. The current definition of sepsis is a dysregulated host response to infection resulti...
Taylor Bay, Krystofer Bagunu, Kanyada Doughty et al.· Critical Care Nursing Quarte...· 0 citations
Sepsis is a life-threatening syndrome of multi-organ dysfunction caused by a dysregulated host response to infection. Despite advances in supportive care, the underlying immunopathological mechanisms remain incompletely understood. A hallmark of sepsis is immunoparalysis, characterized by an early hyperinflammatory pha...